BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28135257)

  • 1. One-step generation of conditional and reversible gene knockouts.
    Andersson-Rolf A; Mustata RC; Merenda A; Kim J; Perera S; Grego T; Andrews K; Tremble K; Silva JC; Fink J; Skarnes WC; Koo BK
    Nat Methods; 2017 Mar; 14(3):287-289. PubMed ID: 28135257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Editing of Mouse Embryonic and Epiblast Stem Cells.
    Sibbritt T; Osteil P; Fan X; Sun J; Salehin N; Knowles H; Shen J; Tam PPL
    Methods Mol Biol; 2019; 1940():77-95. PubMed ID: 30788819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.
    Chow RD; Wang G; Ye L; Codina A; Kim HR; Shen L; Dong MB; Errami Y; Chen S
    Nat Methods; 2019 May; 16(5):405-408. PubMed ID: 30962622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of FLIP and FLIP-FlpE Targeting Vectors for Biallelic Conditional and Reversible Gene Knockouts in Mouse and Human Cells.
    Koo BK
    Methods Mol Biol; 2018; 1842():255-264. PubMed ID: 30196416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More specific CRISPR editing.
    de Souza N
    Nat Methods; 2014 Jul; 11(7):712. PubMed ID: 25110782
    [No Abstract]   [Full Text] [Related]  

  • 9. Guide RNAs: it's good to be choosy.
    Marx V
    Nat Methods; 2020 Dec; 17(12):1179-1182. PubMed ID: 33154568
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts.
    Martufi M; Good RB; Rapiteanu R; Schmidt T; Patili E; Tvermosegaard K; New M; Nanthakumar CB; Betts J; Blanchard AD; Maratou K
    CRISPR J; 2019 Feb; 2(1):31-40. PubMed ID: 31021235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
    Alagoz M; Kherad N
    Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer.
    Merenda A; Andersson-Rolf A; Mustata RC; Li T; Kim H; Koo BK
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CRISPR/Cas9 for the Modification of the Mouse Genome.
    Klimke A; Güttler S; Kuballa P; Janzen S; Ortmann S; Flora A
    Methods Mol Biol; 2019; 1953():213-230. PubMed ID: 30912024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
    Morisaka H; Yoshimi K; Okuzaki Y; Gee P; Kunihiro Y; Sonpho E; Xu H; Sasakawa N; Naito Y; Nakada S; Yamamoto T; Sano S; Hotta A; Takeda J; Mashimo T
    Nat Commun; 2019 Dec; 10(1):5302. PubMed ID: 31811138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.